Description
Product details
BUDEPRESS FORTE 400 combines powerful inhalation therapy ingredients to manage asthma and chronic obstructive pulmonary disease (COPD). This medication contains Formoterol Fumarate (12 mcg) and Budesonide IP (400 mcg), working together to alleviate and prevent respiratory symptoms including wheezing, shortness of breath, chest constriction, and chronic coughing. It delivers both sustained control and quick symptom relief, enhancing lung function and life quality. Active Components: Formoterol Fumarate (12 mcg) A long-acting beta-2 adrenergic agonist (LABA) that delivers quick and extended bronchodilation by relaxing airway muscles. Effects begin within minutes and continue for up to 12 hours, making it excellent for ongoing therapy. Budesonide IP (400 mcg) A strong inhaled corticosteroid (ICS) that reduces lung inflammation, swelling, and mucus production—primary factors contributing to asthma and COPD symptoms. Primary Advantages: Combination therapy featuring both bronchodilator and anti-inflammatory for comprehensive respiratory management. Quick relief from bronchial constriction and breathing difficulties. Extended symptom control lasting up to 12 hours with regular administration. Reduces asthma attack frequency and COPD flare-up severity. Enhances respiratory function for easier, more comfortable breathing. Requires fewer daily doses compared to short-acting alternatives. Appropriate for moderate to severe respiratory conditions under medical guidance. Mechanism of Action: BUDEPRESS FORTE 400 operates through complementary actions of its two key ingredients: Formoterol Fumarate eases bronchial tube smooth muscles, creating airway expansion and rapid relief from narrowing that causes breathing distress. Budesonide, as an anti-inflammatory steroid, addresses underlying airway inflammation causing chronic symptoms and exacerbations. It diminishes hyperresponsiveness and mucus accumulation with consistent use. Together, they prevent airway tightening, decrease inflammation, and facilitate smooth airflow, offering better management of chronic respiratory conditions. Usage Instructions: Use only as prescribed by your healthcare provider. Typically administered twice daily (morning and evening), though dosage may vary based on condition severity and individual response. Shake inhaler thoroughly before each use. Rinse mouth completely with water after each use to avoid oral thrush (fungal infection). Never exceed the prescribed dosage. For effective management, maintain consistent use even when symptoms improve. Potential Side Effects: Most patients tolerate BUDEPRESS FORTE 400 well, though side effects may occur: Common Effects: Voice changes or hoarseness Dry mouth or throat irritation Coughing or throat discomfort Headache Mild trembling or shakiness Elevated heart rate (palpitations) Less Common but Serious Effects: Oral or throat fungal infection (thrush) Allergic responses (rash, swelling, breathing difficulty) Muscle cramping Chest discomfort Worsening respiratory issues (paradoxical bronchospasm) Contact your physician immediately for persistent or severe side effects. Important Precautions: Not for acute asthma attack treatment—always maintain a rescue inhaler for emergencies. Inform your doctor about heart conditions, diabetes, thyroid disorders, or liver issues. Avoid exposure to contagious diseases (e.g., chickenpox, measles) while using corticosteroid therapy. Pregnant or nursing women should consult healthcare providers before using. Store securely away from children. BUDEPRESS FORTE 400 provides a clinically validated, dual-action approach to respiratory comfort—combining immediate relief with long-term management. With proper medical supervision, it significantly improves daily activity levels and decreases respiratory symptom burden.